(Q41668621)
Statements
Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitors (English)
Gerit-Holger Schernthaner
Dominik Wolf
Philipp le Coutre
18 December 2014
scientific article published on 18 December 2014
No description defined